These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1391419)

  • 1. Studies on blood substitutes based on hemoglobin and perfluorocarbon.
    Biro GP; Jing N; Anderson PJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1013-20. PubMed ID: 1391419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic hemodynamic and renal effects of unmodified human SFHS in dogs.
    Ning J; Peterson LM; Anderson PJ; Biro GP
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):723-7. PubMed ID: 1391502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stroma-free hemoglobin solutions on isolated perfused rabbit hearts and isolated perfused rat kidneys.
    Vogel WM; Lieberthal W; Apstein CS; Levinsky N; Valeri CR
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):227-35. PubMed ID: 3140918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5-dibromosalicyl)fumarate cross-linked hemoglobin (alpha alpha Hb).
    Macdonald VW; Motterlini R
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):565-75. PubMed ID: 7994376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin.
    Lieberthal W; Fuhro R; Freedman JE; Toolan G; Loscalzo J; Valeri CR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1278-87. PubMed ID: 10027869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions.
    Lieberthal W; Fuhro R; Alam H; Rhee P; Szebeni J; Hechtman HB; Favuzza J; Veech RL; Valeri CR
    Shock; 2002 Jan; 17(1):61-9. PubMed ID: 11795671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary vasoconstrictor activity of purified and modified human hemoglobin.
    Macdonald VW; Winslow RM; Marini MA; Klinker MT
    Biomater Artif Cells Artif Organs; 1990; 18(2):263-82. PubMed ID: 2369650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vascular actions of stroma-free hemoglobin preparations.
    Biro GP; Taichman GC; Lada B; Keon WJ; Rosen AL; Sehgal LR
    Artif Organs; 1988 Feb; 12(1):40-50. PubMed ID: 3355384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroma-free hemoglobin solutions prepared by crystallization and ultrafiltration methods; comparison of composition and coronary vasoconstrictor potency.
    Lang ME; Korecky B; Anderson PJ; Biro GP
    Adv Exp Med Biol; 1990; 277():225-36. PubMed ID: 2096628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of different preparations of stroma free hemolysates in the isolated perfused rat kidney.
    Lieberthal W; Wolf EF; Merrill EW; Levinsky NG; Valeri CR
    Life Sci; 1987 Dec; 41(23):2525-33. PubMed ID: 3683088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the mechanism of the vasoconstrictor activity of stroma-free hemoglobin in the isolated perfused rat kidney and rabbit heart.
    Lieberthal W; Vogel WM; Apstein CS; Valeri CR
    Prog Clin Biol Res; 1989; 319():407-20; discussion 421-2. PubMed ID: 2622922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoconstriction and the efficacy of hemoglobin-based blood substitutes.
    Winslow RM
    Transfus Clin Biol; 1994; 1(1):9-14. PubMed ID: 8186857
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute beneficial effect of Fluosol-DA on urinary excretion of stroma-free hemoglobin in the isolated rat kidney.
    Millis RM; Barber JD; Anderson WA; Dehkordi O; Toussaint RM; Ertugrul L
    Ren Fail; 1994; 16(3):325-35. PubMed ID: 8059016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physiologic effects of oxygen transport by hemoglobin solutions.
    Moores WY; White FC; Bloor C; Greenburg AG; Mack R; Willford DC
    Prog Clin Biol Res; 1983; 122():89-99. PubMed ID: 6878384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram.
    Yu B; Liu Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):159-73. PubMed ID: 16537172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diasprin cross-linked hemoglobin (DCLHb) on cardiac function and ECG in the swine.
    McKenzie JE; Cost EA; Scandling DM; Savage RW
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):683-7. PubMed ID: 1391496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase in stroma-free hemoglobin solution is not responsible for coronary vasoconstriction.
    Lawless K; Anderson PJ; Biro GP
    Adv Exp Med Biol; 1989; 248():365-70. PubMed ID: 2782159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.
    Taverne YJ; de Wijs-Meijler D; Te Lintel Hekkert M; Moon-Massat PF; Dubé GP; Duncker DJ; Merkus D
    J Appl Physiol (1985); 2017 May; 122(5):1227-1237. PubMed ID: 28183818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide.
    Thompson A; McGarry AE; Valeri CR; Lieberthal W
    J Appl Physiol (1985); 1994 Nov; 77(5):2348-54. PubMed ID: 7868454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced coronary vasoconstrictor activity of hemoglobin solutions purified by ATP-agarose affinity chromatography.
    Vogel WM; Hsia JC; Briggs LL; Er SS; Cassidy G; Apstein CS; Valeri CR
    Life Sci; 1987 Jul; 41(1):89-93. PubMed ID: 3600177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.